In vivo xenograft model of ovarian cancer

XL Xiao Li
CW Caixia Wang
SW Shuang Wang
YH Yuexin Hu
SJ Shan Jin
OL Ouxuan Liu
RG Rui Gou
XN Xin Nie
JL Juanjuan Liu
BL Bei Lin
request Request a Protocol
ask Ask a question
Favorite

Twenty female nude mice (Huafukang Biosciences, Beijing, China) were randomly divided into two groups and injected with either OVCAR3-YWHAE-MOCK or OVCAR3-YWHAE-H ovarian cancer cells. Approximately 100 µL of cell suspension containing 1 × 107 cells was injected subcutaneously into the armpit of the right forelimb of each mouse. Tumour progression and overall health status of the mice were observed every 3 days, and the diameter of the tumour and the weight of the mice were measured. The tumour volume was calculated using the following formula: V = (a × b2)/2, where (a) represents the largest diameter, and (b) the shortest diameter. On day 7 post-injection, newly formed tumours were detectable; on day 21, the largest tumour was nearly 1 cm in diameter, and the mice had started to show poor health symptoms. The tumour samples were then fixed in 4% paraformaldehyde and embedded in paraffin. Continuous 5 μm-thick sections were cut and analysed using either haematoxylin and eosin or immunohistochemical staining. This animal study was approved by the Institutional Animal Research Committee of China Medical University.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A